Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Paliperidone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 42,440Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sumitomo to market Johnson & Johnson's schizophrenia drug in Japan
    Sumitomo to market Johnson & Johnson's schizophrenia drug in Japan

    21 Jan 2025

    // BIOSPECTRUM

    https://www.biospectrumasia.com/news/25/25470/sumitomo-to-market-johnson-johnsons-schizophrenia-drug-in-japan.html

    BIOSPECTRUM
    21 Jan 2025
    Share Share
    Zydus Pharma`s Generics Paliperidone Receives Approval in US
    Zydus Pharma`s Generics Paliperidone Receives Approval in US

    08 Oct 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217445

    FDA
    08 Oct 2024
    Share Share
    Alembic Pharma gets USFDA nod for schizophrenia Drug
    Alembic Pharma gets USFDA nod for schizophrenia Drug

    28 Sep 2024

    // ECOMONICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-gets-usfda-nod-for-generic-drug-used-to-treat-schizophrenia/articleshow/113737767.cms

    ECOMONICTIMES
    28 Sep 2024
    Share Share
    Alembic`s Generics Paliperidone Receives Approval in US
    Alembic`s Generics Paliperidone Receives Approval in US

    26 Sep 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218330

    FDA
    26 Sep 2024
    Share Share
    Ajanta Pharma's Generic Paliperidone Receives Approval in US
    Ajanta Pharma's Generic Paliperidone Receives Approval in US

    26 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218514

    FDA
    26 Jun 2024
    Share Share
    Ascent Pharma' Generic Paliperidone Receives Approval in the U.S.
    Ascent Pharma' Generic Paliperidone Receives Approval in the U.S.

    23 Aug 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216174

    FDA
    23 Aug 2023
    Share Share